We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Upholds One Gemzar Patent, Lilly Appeals on Second Patent
Court Upholds One Gemzar Patent, Lilly Appeals on Second Patent
April 13, 2010
Eli Lilly has won a federal court decision affirming patent protection on its cancer treatment Gemzar until later this year, but the court declined to uphold a second patent that would have protected the drug until 2013.